Fundamental Analysis
22 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -90.8% | -30.6% | 1 / 3 | -98.0% | -135.64 pp | -544.00 pp | -64.5% | 0.57 | — | 1,0 | −98,0% | −5,6 | −220,7% | — | -3.18 | — |
| Pts | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 3.000 (close price on 2026-10-16)EPS (TTM): −554,0
Financial charts
1.Revenue & growth
VND bn1,03Q3/26
1.Revenue & growth
VND bn1,03Q3/26
2.Profit & growth
VND bn-5,62Q3/26
3.Profit mix (Penman)
VND bn-18,6Q3/26
4.Margins & cost structure
%-14.9%Q3/26
5.Returns & cash cycle
% · days
6.Earnings quality & cash
VND bn-12,3Q3/26
7.Asset structure
VND bn237Q3/26
8.Funding & debt health
VND bn · times237Q3/26
9.Revenue backlog
VND bn1,52Q3/26
10.Valuation
times · %-5,2×Q3/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-114Q3/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
No comparable quarter a year earlier
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
Share history could not be reconciled
Source: vnstockData through Q3/26